Related Experiment Video
Updated: May 26, 2026
08:13
Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
Published on: September 30, 2021
Pediatric hemophilia: a review
Roshni Kulkarni1, J Michael Soucie
1Department of Pediatrics and Human Development, Michigan State University, East Lansing, Michigan 48824, USA. Roshni.Kulkarni@hc.msu.edu
Seminars in Thrombosis and Hemostasis
|December 22, 2011
Summary
Hemophilias, common X-linked bleeding disorders, present unique challenges in newborns versus older patients. Early recognition and prophylaxis are key to preventing complications like intracranial hemorrhage (ICH).
Area of Science:
- Hematology
- Pediatrics
- Genetics
Background:
- Hemophilias are prevalent X-linked inherited bleeding disorders requiring careful management to prevent chronic illness and disability.
- Clinical manifestations and management challenges in hemophilia differ significantly between newborns and older individuals.
Purpose of the Study:
- To highlight the age-specific bleeding sites and complications in pediatric hemophilia.
- To emphasize the importance of early diagnosis, appropriate management, and preventive strategies, including prophylaxis.
Main Methods:
- This study reviews the clinical presentations and management considerations for hemophilia across different pediatric age groups.
- It synthesizes current understanding of bleeding patterns, common complications, and evolving treatment paradigms.
Main Results:
- Bleeding events are primary diagnostic indicators in children, with specific sites varying by age.
- Newborns are prone to delivery-associated intracranial hemorrhage (ICH), bleeding after circumcision, and venipuncture issues.
- Older children and adolescents face risks of joint disease and bleeding from head trauma.
Conclusions:
- Awareness of age-specific clinical features and potential treatment complications is vital for effective hemophilia care.
- Inhibitors and ICH remain significant challenges, with prophylaxis emerging as the preferred preventive strategy for optimal outcomes.
Related Concept Videos
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:05Introduction to Hemostasis
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...